Dallas Section Meeting

Topic: Translational applications of dendrimers for drug and gene delivery

The presentation addresses cutting-edge research to improve therapeutic index & drug properties, achieve controlled release, enable non-invasive alternative administration and improve patient compliance; and foster translational and convergence research and education. Challenges facing drug delivery in medication management and therapy are addressed with active development of novel polymers, polymer-drug coupling chemistries, and creative approaches and models. The focus of ongoing projects include engineering of dendrimers for efficient drug and gene delivery and their translational applications for cancer, ocular and cardiovascular diseases.

Biography: Dr. Hu Yang is Department Chair and Professor in the Linda and Bipin Doshi Department of Chemical and Biochemical Engineering at Missouri University of Science and Technology (Missouri S&T). He is Linda and Bipin Doshi Endowed Chair. Dr. Yang received his Ph.D. in Chemical Engineering from the University of Akron in 2004, followed by postdoctoral research in pharmaceutical sciences at the University of Wisconsin-Madison between 2004 and 2005. In the fall of 2005, he started his independent career with appointments with chemical and life science engineering, biomedical engineering, and pharmaceutics at Virginia Commonwealth University (VCU). He moved up in rank from Assistant Professor to Professor while he was there. He held Qimonda Endowed Chair Professorship until July 2020 when he assumed the Chair position at Missouri S&T. Dr. Yang received the prestigious Wallace Coulter Young Investigator Award in 2009 and the NSF CAREER Award in 2010. Dr. Yang is scholarly productive, and his research has been primarily funded by the National Institutes of Health. According to a report by Stanford University, Dr. Yang is among the world’s top 2% of most-cited scientists in the Biomedical Engineering discipline.